The patent describes a technology that allows a new generation of non-invasive ultrasound therapy for both fat and wrinkle reduction targeted for patients worldwide.

NivaSonix has developed a differentiating way to selectively deliver ultrasound energy based on its proprietary ‘Sweeping Multizone Focus’ (SMF) technology.

The NivaSonix Ullisys system is based on a flexible and expandable product platform, designed for both skin tightening (wrinkle reduction) and lipoplasty (fat emulsification).

NivaSonix president and CEO Bobby Purkait said they are pleased to receive the notice of allowance of our patent – this innovative, broad technology and product should benefit both patients and surgeons.